Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-004714

Options or other derivatives

  • President and CEO acquired 124,997 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-11 Grant or award : show line 1 in the form Restricted Stock Units +124,997 124,997 D
Loading xslF345X03/ownership.xml…